Study 2*100501834
|
Visible Platform MWM Test100500097
|
F1 Female Wistar Rat100500211
|
Swimming Speed (cm/s)100501721
|
ppm |
- |
- |
- |
- |
Study 2*100501834
|
Visible Platform MWM Test100500097
|
F1 Female Wistar Rat100500211
|
Escape Latency to Visible Platform (s)100501722
|
ppm |
- |
- |
- |
- |
Study 2*100501834
|
Acute Nicotine Exposure100500209
|
Male Wistar Rats100500453
|
Escape Latency Block 1100504055
|
ppm |
- |
- |
- |
- |
Study 5100501832
|
14 day body weight study100500092
|
Male ob/ob mice100500205
|
body weight100501694
|
ppm |
- |
- |
- |
- |
Study 6*100501836
|
18-week Immunotoxicity100500095
|
Male Wistar Rats100500209
|
Body Weight Change100501709
|
ppm |
- |
- |
- |
- |
Study 6*100501836
|
18-week Immunotoxicity100500095
|
Male Wistar Rats100500209
|
Malondialdehyde (MDA) equivalent levels100501710
|
ppm |
4.0 |
40.0 |
- |
- |
Study 6*100501836
|
18-week Immunotoxicity100500095
|
Male Wistar Rats100500209
|
Liver histopathology100501713
|
ppm |
0.4 |
4.0 |
- |
- |
Study 7100501843
|
Mid-pregnancy rat oral study100500111
|
Mid-pregnancy rat oral study100500236
|
Mid-pregnancy rat oral study100502148
|
ppm |
- |
- |
- |
- |
Study 8*100502328
|
10-Day Oral100500124
|
F1 female Bom:NMRI mice,100500269
|
Fertility100502255
|
ppm |
- |
- |
- |
- |
Study 8*100502328
|
10-Day Oral100500124
|
F1 female Bom:NMRI mice,100500269
|
Fertility100502298
|
ppm |
- |
- |
- |
- |
Study 9100501842
|
Neurobehavioral effects from developmental exposures100500094
|
0.1% DMSO Adult 5D Zebrafish100500208
|
Learning and Memory - Time Shocked - Learned100501706
|
ppm |
- |
- |
- |
- |
Study 9100501842
|
Neurobehavioral effects from developmental exposures100500094
|
0.1% DMSO Adult 5D Zebrafish100500208
|
Learning and Memory - Decision Time - Learned100501707
|
ppm |
- |
- |
- |
- |
Study 9100501842
|
Neurobehavioral effects from developmental exposures100500094
|
0.1% DMSO Adult 5D Zebrafish100500208
|
Learning and Memory - Time on Correct Side - Learned100501708
|
ppm |
- |
- |
- |
- |